Episode 27: Interview with Grace Colón, CEO of InCarda

In this episode, we interview Grace Colón who is the CEO of InCarda. Grace has over 25 years of experience in biopharma, genomics, healthcare, and industrial biotechnology. Grace is Executive Chairman (formerly CEO) of ProterixBio and serves on the boards of CareDx (NASDAQ:CDNA) and Cocoon Biotech and on the Advisory Board of the Miller Center for Social Entrepreneurship at Santa Clara University. Formerly, she was a partner at New Science Ventures, a New York-based venture capital firm with over $700M under management, and served on the boards of Paradigm Diagnostics and PerceptiMed. Dr. Colón received her Ph.D. in chemical engineering from the Massachusetts Institute of Technology, where she was an NSF Fellow.